{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:21Z","timestamp":1794047481290,"version":"4.8.0"},"reference-count":10,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"10","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.285368","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:36:59Z","timestamp":1718293019000},"page":"3414-3418","source":"Crossref","is-referenced-by-count":3,"title":["Soluble SLAMF7 is generated by alternative splicing in multiple myeloma cells"],"prefix":"10.3324","volume":"109","author":[{"given":"Jiro","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kakugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Tenshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"67660","doi-asserted-by":"crossref","unstructured":"Facon T, Kumar SK, Plesner T. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial. Lancet Oncol. 2021; 22(11):1582-1596.","DOI":"10.1016\/S1470-2045(21)00466-6"},{"key":"67661","doi-asserted-by":"crossref","unstructured":"Pawlyn C, Cairns D, Kaiser M. The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial. Leukemia. 2020; 34(2):604-612.","DOI":"10.1038\/s41375-019-0595-5"},{"key":"67662","doi-asserted-by":"crossref","unstructured":"Tirier SM, Mallm JP, Steiger S. Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single-cell transcriptomics. Nat Commun. 2021; 12(1):6960.","DOI":"10.1038\/s41467-021-26951-z"},{"key":"67663","doi-asserted-by":"crossref","unstructured":"Kikuchi J, Hori M, Iha H. Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7. Leukemia. 2020; 34(1):180-195.","DOI":"10.1038\/s41375-019-0525-6"},{"key":"67664","doi-asserted-by":"crossref","unstructured":"Ishibashi M, Soeda S, Sasaki M. Clinical impact of serum soluble SLAMF7 in multiple myeloma. Oncotarget. 2018; 9(78):34784-34793.","DOI":"10.18632\/oncotarget.26196"},{"key":"67665","doi-asserted-by":"crossref","unstructured":"Suzuki A, Kakugawa S, Miyoshi M. Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy. Leukemia. 2020; 34(11):3088-3090.","DOI":"10.1038\/s41375-020-0860-7"},{"key":"67666","doi-asserted-by":"crossref","unstructured":"Kikuchi J, Kodama N, Takeshita M. Extramedullary multiple myeloma originates from hyaluronan-induced homophilic cellcell interactions of CD44 variant-expressing myeloma cells under shear stress. Blood Adv. 2023; 7(4):508-524.","DOI":"10.1182\/bloodadvances.2022007291"},{"key":"67667","doi-asserted-by":"crossref","unstructured":"Simmons DP, Nguyen HN, Gomez-Rivas E. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci Immunol. 2022; 7(68):eabf2846.","DOI":"10.1126\/sciimmunol.abf2846"},{"key":"67668","doi-asserted-by":"crossref","unstructured":"O\u2019Connell P, Hyslop S, Blake MK. SLAMF7 signaling reprograms T cells toward exhaustion in the tumor microenvironment. J Immunol. 2021; 206(1):193-205.","DOI":"10.4049\/jimmunol.2000300"},{"key":"67669","doi-asserted-by":"crossref","unstructured":"Awwad MHS, Mahmoud A, Bruns H, Echchannaoui H, Kriegsmann K, Lutz R. Selective elimination of immunosuppressive T cells in patients with multiple myeloma. Leukemia. 2021; 35(9):2602-2615.","DOI":"10.1038\/s41375-021-01172-x"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285368\/77133","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285368\/77590","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11649\/77133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:06:41Z","timestamp":1794046001000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":10,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285368","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}